Unknown

Dataset Information

0

Evaluation of islets derived from human fetal pancreatic progenitor cells in diabetes treatment.


ABSTRACT: INTRODUCTION: With the shortage of donor organs for islet transplantation, insulin-producing cells have been generated from different types of stem cell. Human fetal pancreatic stem cells have a better self-renewal capacity than adult stem cells and can readily differentiate into pancreatic endocrine cells, making them a potential source for islets in diabetes treatment. In the present study, the functions of pancreatic islets derived from human fetal pancreatic progenitor cells were evaluated in vitro and in vivo. METHODS: Human pancreatic progenitor cells isolated from the fetal pancreas were expanded and differentiated into islet endocrine cells in culture. Markers for endocrine and exocrine functions as well as those for alpha and beta cells were analyzed by immunofluorescent staining and enzyme-linked immunosorbent assay (ELISA). To evaluate the functions of these islets in vivo, the islet-like structures were transplanted into renal capsules of diabetic nude mice. Immunohistochemical staining for human C-peptide and human mitochondrion antigen was applied to confirm the human origin and the survival of grafted islets. RESULTS: Human fetal pancreatic progenitor cells were able to expand in medium containing basic fibroblast growth factor (bFGF) and leukemia inhibitor factor (LIF), and to differentiate into pancreatic endocrine cells with high efficiency upon the actions of glucagon-like peptide-1 and activin-A. The differentiated cells expressed insulin, glucagon, glucose transporter-1 (GLUT1), GLUT2 and voltage-dependent calcium channel (VDCC), and were able to aggregate into islet-like structures containing alpha and beta cells upon suspension. These structures expressed and released a higher level of insulin than adhesion cultured cells, and helped to maintain normoglycemia in diabetic nude mice after transplantation. CONCLUSIONS: Human fetal pancreatic progenitor cells have good capacity for generating insulin producing cells and provide a promising potential source for diabetes treatment.

SUBMITTER: Zhang WJ 

PROVIDER: S-EPMC4055010 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

altmetric image

Publications

Evaluation of islets derived from human fetal pancreatic progenitor cells in diabetes treatment.

Zhang Wen-Jian WJ   Xu Shi-Qing SQ   Cai Han-Qing HQ   Men Xiu-Li XL   Wang Zai Z   Lin Hua H   Chen Li L   Jiang Yong-Wei YW   Liu Hong-Lin HL   Li Cheng-Hui CH   Sui Wei-Guo WG   Deng Hong-Kui HK   Lou Jin-Ning JN  

Stem cell research & therapy 20130101 6


<h4>Introduction</h4>With the shortage of donor organs for islet transplantation, insulin-producing cells have been generated from different types of stem cell. Human fetal pancreatic stem cells have a better self-renewal capacity than adult stem cells and can readily differentiate into pancreatic endocrine cells, making them a potential source for islets in diabetes treatment. In the present study, the functions of pancreatic islets derived from human fetal pancreatic progenitor cells were eval  ...[more]

Similar Datasets

| S-EPMC7563383 | biostudies-literature
| S-EPMC3537170 | biostudies-literature
| S-EPMC6719489 | biostudies-literature
| S-EPMC4400611 | biostudies-literature
| S-EPMC5488369 | biostudies-literature
| S-EPMC5248995 | biostudies-literature
| S-EPMC4293092 | biostudies-literature
| S-EPMC3555946 | biostudies-literature
| S-EPMC5504025 | biostudies-literature
| S-EPMC3402300 | biostudies-literature